> The skepticism shows no sign of slowing, YouGov reports. While trust for the Pfizer and Moderna vaccines rose in all country surveys between December and March, trust for the AZ vaccine slipped in Germany over that span. By early March, 40% said the AZ vaccine was unsafe, an increase of 10% since its earlier December poll.
> The result? Anecdotal reports in Germany and across Europe of people refusing the AZ vaccine and supplies sitting unused in warehouse, YouGov reported—real-world evidence of “the extent of the damage done to the perceived safety of AstraZeneca vaccine.”
> The AstraZeneca jab, which is cheaper to produce and easier to store and distribute than the vaccines currently being administered across Europe from Pfizer-BioNTech and Moderna, was meant to be a workhorse of the continent’s vaccination drive. That plan could be in trouble, however, if citizens across Europe continue to believe that the AstraZeneca vaccine is unsafe and, as a result, refuse to bare their arms for it.
I believe there are significant public health implications to how information is released to the public that need to be considered better than they have been in the case of this pause and the similar case with the AZ vaccine.
I believe, as with software, that immediate release of unvetted, incomplete, and still-being-investigated information can be actively harmful to people.
The goal is to avoid this sort of consequence:
https://www.fiercepharma.com/marketing/yougov-poll-finds-dis...
> The skepticism shows no sign of slowing, YouGov reports. While trust for the Pfizer and Moderna vaccines rose in all country surveys between December and March, trust for the AZ vaccine slipped in Germany over that span. By early March, 40% said the AZ vaccine was unsafe, an increase of 10% since its earlier December poll.
> The result? Anecdotal reports in Germany and across Europe of people refusing the AZ vaccine and supplies sitting unused in warehouse, YouGov reported—real-world evidence of “the extent of the damage done to the perceived safety of AstraZeneca vaccine.”
https://www.economist.com/graphic-detail/2021/03/22/increasi...
> The AstraZeneca jab, which is cheaper to produce and easier to store and distribute than the vaccines currently being administered across Europe from Pfizer-BioNTech and Moderna, was meant to be a workhorse of the continent’s vaccination drive. That plan could be in trouble, however, if citizens across Europe continue to believe that the AstraZeneca vaccine is unsafe and, as a result, refuse to bare their arms for it.